U.S. and worldwide patent filings strengthen proprietary positions of clinivation’s unique and differentiated solutions.
Framingham, MA, April 2, 2002 – clinivation, Inc. announced today that it continues to build, expand, and strengthen the proprietary positions of its unique and differentiated solutions with multiple U.S. and international patent filings.
“Clinivation’s strategy since inception has been to develop and protect unique and highly-differentiated solutions with patents to cover the architecture, functionality, and features that enable the solutions to deliver high levels of process automation, process acceleration, and value to end-users,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer. “Because our team has deep vertical experience in the medical product commercialization processes, and because we work so closely with end-users across all medical product industry segments, we believe that the approaches for which we are securing proprietary positions are important,” he continued.
“We are also pleased to have received numerous, favorable validity and infringement positions from our superb legal counsel in Boston and Washington,” said Dr. Kozikowski.
Proprietary positions have been achieved for clinivation’s decision-support commercial strategy analytics solution as well as for other solutions addressing clinical development, quality systems, and other business processes.
